Does Umeclidinium Monotherapy Help Asthma Patients Without ICS? – Monthly Prescribing Reference

Does Umeclidinium Monotherapy Help Asthma Patients Without ICS?
Monthly Prescribing Reference
However, no studies have assessed a long-acting muscarinic antagonist in the absence of inhaled corticosteroids (ICS) for asthma patients. A new study in Respiratory Medicine reports on a double-blind, three-period crossover study of 350 asthma

View full post on asthma – Google News

A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Umeclidinium bromide/Vilanterol;   Drug: Placebo ACCUHALER/DISKUS;   Drug: Fluticasone propionate/Salmeterol;   Drug: Placebo NDPI
Sponsors:   GlaxoSmithKline;   GlaxoSmithKline
Not yet recruiting – verified April 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days